A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
מצבים רפואיים
Alopecia Areata
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Center For Dermatology Clinical Research, Inc., Fremont, California, United States
Contact: Principal Investigator (Sunil Dhawan)Northridge Clinical Trials, Northridge, California, United States
Contact: Principal Investigator (Navid Ezra)Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway, Santa Clarita, California, United States
Contact: Principal Investigator (Bernard Raskin)Health Clinical Research, LLC, Cutler Bay, Florida, United States
Contact: Principal Investigator (Soroush Aghigh)Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Arash Mostaghimi)Revival Research Institute, LLC, Troy, Michigan, United States
Contact: Principal Investigator (Ali Moiin)Stracskin, Portsmouth, New Hampshire, United States
Contact: Principal Investigator (Abel Jarell)Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue, San Antonio, Texas, United States
Contact: Principal Investigator (John Browning)Jordan Valley Dermatology & Research Center, South Jordan, Utah, United States
Contact: Principal Investigator (Douglass Forsha)Kelowna Health and Memory Centre, Kelowna, Canada
Contact: Principal Investigator (Nicola Gray)Ryan Clinical Research Inc., Newmarket, Canada
Contact: Principal Investigator (Sanjay Siddha)Dar Clinical Research - Ottawa - Hunt Club Road, Ottawa, Canada
Contact: Principal Investigator (Reetesh Bose)SIMa Recherche, Verdun, Canada
Contact: Principal Investigator (Simon Nigen)Beijing Friendship Hospital Affiliate of Capital University, Beijing, China
Contact: Principal Investigator (Fenglin Zhuo)Huashan Hospital, Fudan University, Shanghai, China
Contact: Principal Investigator (Wenyu Wu)Shanghai Skin Disease Hospital, Shanghai, China
Contact: Principal Investigator (Yuling Shi)Tianjin Medical University General Hospital, Tianjin, China
Contact: Principal Investigator (Huiping Wang)Erasmus Medisch Centrum, Rotterdam, Netherlands
Contact: Principal Investigator (Rick Waalboer-Spuij)Centrum Badan Klinicznych PI-House sp. z o.o., Gdansk, Poland
Contact: Principal Investigator (Aleksandra Okuniewska)Diamond Clinic, Krakow, Poland
Contact: Principal Investigator (Barbara Rewerska)Dermedic Jacek Zdybski, Ostrowiec Świętokrzyski, Poland
Contact: Principal Investigator (Jacek Zdybski)Centrum Medyczne Ginemedica, Wroclaw, Poland
Contact: Principal Investigator (Justyna Kwapisz)Chung-Ang University Hospital, Dongjak-gu, South Korea
Contact: Principal Investigator (Beomjoon Kim)Inha University Hospital, Incheon, South Korea
Contact: Principal Investigator (Gwang Seong Choi)Jeonbuk National University Hospital, Jeonju, South Korea
Contact: Principal Investigator (Jin Park)Seoul National University Hospital, Seoul, South Korea
Contact: Principal Investigator (OHSANG KWON)Kyung Hee University Hospital at Gangdong, Seoul, South Korea
Contact: Principal Investigator (Bark Lynn Lew)Royal London Hospital, London, United Kingdom
Contact: Principal Investigator (Maria Angeliki Gkini)Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Leila Asfour)Salford Royal Hospital, Salford, United Kingdom
Contact: Principal Investigator (Matthew Harries)
מובילי המחקר
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)
Study Director
Eli Lilly and Company